Invention Grant
- Patent Title: FRET protease assays for clostridial toxins
-
Application No.: US12620388Application Date: 2009-11-17
-
Publication No.: US08048643B2Publication Date: 2011-11-01
- Inventor: Lance E. Steward , Ester Fernandez-Salas , Kei Roger Aoki
- Applicant: Lance E. Steward , Ester Fernandez-Salas , Kei Roger Aoki
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Kenton Abel; Debra Condino
- Main IPC: C12Q1/37
- IPC: C12Q1/37 ; A61K38/00 ; G01N33/533 ; C07K7/00 ; C07K14/00

Abstract:
The present invention provides clostridial toxin substrates useful in assaying for the protease activity of any clostridial toxin, including botulinum toxins of all serotypes as well as tetanus toxins. A clostridial toxin substrate of the invention contains a donor fluorophore; an acceptor having an absorbance spectrum overlapping the emission spectrum of the donor fluorophore; and a clostridial toxin recognition sequence that includes a cleavage site, where the cleavage site intervenes between the donor fluorophore and the acceptor and where, under the appropriate conditions, resonance energy transfer is exhibited between the donor fluorophore and the acceptor.
Public/Granted literature
- US20100075357A1 FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS Public/Granted day:2010-03-25
Information query